Blotting the tumor lysates for MES markers (fibronectin, CD44, and CTGF) revealed that LN229TAZ(4SA) tumors express these proteins at higher levels, suggesting a MES transformation in vivo (Fig. 1c). This evidence concerns the gene CD44 and neoplasm.